Search PubMed⌕ Search

Biomedical subjects

J J Sando

Publications and source records attributed to J J Sando.

At least 37 records · Page 2Linked to original sources
PubMed1992

Effect of phospholipid unsaturation on protein kinase C activation.

To examine the hypothesis that physical features of the membrane contribute to protein kinase C activation, phosphatidylcholine/phosphatidylserine/diolein (70:25:5) vesicles of defined acyl chain composition were tested for their ability to activate the enzyme. Maximal activation was found to correlate with the mole percent unsaturation in the system. Unsaturation could be provided by either the phosphatidylserine or the phosphatidylcholine component. Vesicles containing 5 mol% diolein but lacking any unsaturation in the phospholipid did not support activity, indicating that acidic head groups alone are not sufficient for activity. The saturated lipid vesicles could be rendered effective but only at very high (25 mol%) concentrations of diolein. The degree of acyl chain unsaturation and the positioning of the double bond had little effect on the activity, suggesting that the effect of the unsaturation is due to some physical property of the lipid rather than to a specific lipid-protein interaction. Addition of cholesterol to both saturated and unsaturated systems indicated that fluidity, as assessed by fluorescence anisotropy, did not correlate with activity. These results suggest that a physical property of the membrane other than fluidity is important for the activation of protein kinase C. A model for protein kinase C activation involving phase separation and/or head group spacing is discussed.

Animals↗
PubMed1992

Regulation of intestinal guanylate cyclase by the heat-stable enterotoxin of Escherichia coli (STa) and protein kinase C.

The heat-stable enterotoxin of Escherichia coli (STa) stimulates membrane-bound guanylate cyclase in intestinal epithelium and induces fluid and ion secretion. Using the T84 human colon carcinoma cell line as a model, we observed that phorbol esters markedly enhanced STa-stimulated cyclic GMP accumulation in T84 cells (C. S. Weikel, C. L. Spann, C. P. Chambers, J. K. Crane, J. Linden, and E. L. Hewlett, Infect. Immun. 58:1402-1407, 1990). In this study we document that the phorbol ester treatment increases 125I-STa-binding sites as well as membrane-bound guanylate cyclase activity in T84 cells and provide evidence that both effects are mediated by phosphorylation. Guanylate cyclase activity was increased approximately 50% in membranes prepared from intact T84 cells treated with phorbol-12,13-dibutyrate (beta-PDB) and after treatment of homogenates with beta-PDB in a manner dependent on ATP, MgCl2, and cytosol. Similarly, treatment of membranes with purified bovine brain protein kinase C in the presence of appropriate cofactors and beta-PDB resulted in an increase in STa-stimulated guanylate cyclase activity of about 70%. Likewise, the number of 125I-STa-binding sites was increased by about 25 to 40% in membranes prepared from intact cells or homogenates treated with beta-PDB; no effect on binding affinity (Kd = 0.15 nM) was noted. These experiments suggest that protein kinase C may phosphorylate the STa receptor-guanylate cyclase or a closely related protein and increase guanylate cyclase activity. The stimulatory effects of protein kinase C on STa-sensitive guanylate cyclase are opposite in direction to the profound inhibitory effects of the kinase on atrial natriuretic peptide-stimulated guanylate cyclase, demonstrating differential regulation by protein kinases within the guanylate cyclase-receptor family.

Adenosine Triphosphate↗
PubMed1991

Protein kinase C isozyme expression in phorbol ester-sensitive and -resistant EL4 thymoma cells.

To investigate whether differential protein kinase C isozyme expression in phorbol ester-sensitive and -resistant EL4 thymoma cells could account for the difference in phorbol ester responsiveness, we purified and characterized isozymes from the two cell lines. In both cell types, two peaks of protein kinase C activity were resolved on hydroxylapatite following DEAE-cellulose and phenyl-Superose chromatography. Western blot analysis showed that the first peak corresponded to protein kinase C-beta and the second to protein kinase C-alpha. Two-dimensional phosphotryptic mapping of the purified alpha and beta isozymes did not reveal any reproducible differences between sensitive and resistant EL4 cells. Nor were any differences between the cell types observed in the cytosolic versus membrane localization of alpha and beta protein kinase C. Northern blot analysis showed the expression of mRNA for protein kinase C-alpha, -beta, -delta and -epsilon in both cell lines, and the absence of mRNA for gamma or zeta. Although no major differences in expression of alpha, beta, or delta mRNA between sensitive and resistant EL4 cells were detectable, expression of protein kinase C-epsilon mRNA in resistant cells was only 20-25% of that in sensitive. Western blot analysis with anti-protein kinase C-epsilon antibodies showed the presence of the epsilon-isozyme in sensitive cells and the absence of detectable amounts in resistant cells. Although protein kinase C-epsilon constitutes only a small portion of the total protein kinase C in sensitive cells, the possibility is raised that decreased protein kinase C-epsilon expression may contribute to the failure of resistant EL4 cells to respond to phorbol esters.

Animals↗
PubMed1991

Defective induction of Jun and Fos-related proteins in phorbol ester-resistant EL4 mouse thymoma cells.

Treatment of sensitive EL4 mouse thymoma cells with phorbol esters causes growth inhibition, adherence to substrate and production of several lymphokines including Interleukin 2. Resistant cells lack all of these responses. Since production of Interleukin 2 mRNA is dependent on protein synthesis, and the Interleukin 2 gene has a phorbol ester responsive element, we examined both cell lines for expression of the various Jun and Fos species which bind to this element. Phorbol ester induced c-fos, jun-B, and jun-D RNAs within 20 min in both cell lines. Fos-B was similarly induced in sensitive cells but induction was delayed and greatly enhanced in resistant cells. C-jun RNA induction was detected only in sensitive cells. Western analysis confirmed the induction of c-Jun and a Fos-related protein in sensitive cells only. Southern analysis indicated that both cell lines contain c-jun and fra-1 genes. These results suggest that defective induction of c-Jun and/or Fos-related proteins may contribute to the absence of phorbol ester-induced lymphokine production in resistant EL4 cells.

Animals↗
PubMed1990

Differential activation of protein kinase C isozymes by short chain phosphatidylserines and phosphatidylcholines.

To investigate the importance of the physical state of phospholipids for activation of protein kinase C, we have used short chain phospholipids, which, depending on their concentration, can exist as either monomers or micelles. We previously reported that short chain phosphatidylcholines (PC) can activate protein kinase C at concentrations that correlate with the critical micelle concentration of the activating lipid (Walker, J. M., and Sando, J. J. (1988) J. Biol. Chem. 263, 4537-4540). We have now expanded this work to short chain phosphatidylserine (PS) systems in order to examine the role of Ca2(+)-phospholipid interactions in the activation process. Short chain PS were synthesized from corresponding PC and purified by reverse-phase high pressure liquid chromatography. Use of the short chain system has revealed significant differences in the activation of type II and type III protein kinase C isozymes. The type II isozyme required Ca2+ in the presence of long chain PS vesicles; in the presence of the short chain phospholipid micelles (PC or PS), most of the activity was Ca2+ independent. Addition of diacylglycerol caused a small increase in type II activity in all phospholipid systems. In contrast, type III protein kinase C was Ca(+)-dependent in all of the lipid systems. The concentration of Ca2+ required to activate type III protein kinase C was independent of the phospholipid type despite large differences in the ability of these lipids to bind Ca2+. This isozyme required diacylglycerol only in the PC micelle system or with vesicles composed of long chain saturated PS. The presence of short chain PS micelles or long chain PS with unsaturated fatty acyl chains rendered this Ca2(+)-dependent protein kinase C virtually diacylglycerol independent. These results are consistent with a model in which type II protein kinase C requires Ca2+ primarily for membrane association, a requirement which is bypassed with the micelle system, whereas type III protein kinase C has an additional Ca2+ requirement for activity that does not involve Ca2(+)-phospholipid interactions.

Animals↗
PubMed1990

Control of lymphokine production by protein kinase C.

As illustrated in Fig. 3, our understanding of lymphokine production is incomplete. Nuclear effects of PKC are probably mediated by phosphorylated substrates. Some of the substrates are themselves being identified as kinases and phosphatases, adding more complexity to the pathway. Use of resistant cell lines is one of the approaches that may help link early phosphorylation events with later transcriptional responses.

Animals↗
PubMed1989

Phosphorylation of protein kinase C by casein kinase-1.

Because phosphorylation of protein kinase C (PKC) may provide a mechanism for regulation of this enzyme, we have examined the ability of two other kinases to phosphorylate PKC. Our results show that casein kinase 1 (CK-1), but not casein kinase 2 (CK-2), can phosphorylate PKC in the absence of Ca2+ and phospholipids. The 32P incorporation into PKC in the presence of Ca2+ and phospholipids is also enhanced by CK-1.

Calcium↗
PubMed1989

Activation of protein kinase C by short chain phospholipid micelles.

PKC (80 kDa) can be cleaved by limited proteolysis into distinct catalytic (50 kDa) and regulatory (32-35 kDa) fragments. After cleavage, the catalytic fragment is active in the absence of Ca2+, phospholipid, or DAG while the regulatory fragment is found associated with phospholipid and continues to bind phorbol esters in a Ca2(+)- and PS-dependent manner (28, 29). In the holoenzyme, the association of the regulatory domain with the membrane may be important to release the catalytic domain from inhibition by the regulatory domain. We have presented evidence indicating that effective membrane binding occurs through interaction with the hydrophobic and/or interfacial regions of the bilayer, and does not result from binding to individual phospholipids. In vivo and in vitro studies suggest that the binding event is carefully regulated. An important function of Ca2+ may be to modify the local structure of the membrane, and thus affect the ability of PKC to associate with it. For at least one of the isozymes, however, Ca2+ may also play an additional role at a site distant from the membrane, suggesting the possibility that the isozymes may be differentially regulated.

Animals↗
PubMed1988

Activation of protein kinase C by short chain phosphatidylcholines.

The acidic phospholipid requirement for protein kinase C (Ca2+/phospholipid-dependent enzyme) activation has been well established, although the molecular nature of this lipid-protein interaction is unclear. The additional requirement for Ca2+ has provided the basis for several models involving charge interactions. We now report that short chain neutral phosphatidylcholines also activate the kinase. Examination of a large series of phosphatidylcholines of varying acyl chain length revealed a close correlation between the ability to form micelles and the ability to support kinase activity. Peak activation occurred in the concentration range just before the critical micelle concentration of each phospholipid. Activation was absolutely dependent on the presence of Ca2+ and diacylglycerol. The possible roles of Ca2+ and phospholipid in the activation process are reexamined in light of these unexpected results.

Animals↗
PubMed1988

Phorbol esters increase adenylate cyclase activity and stability in pituitary membranes.

In this report, we demonstrate that calcium and phorbol esters enhance cAMP production in GH4C1 cell homogenates. The mechanism for this is a reduction in the rate of decay of adenylate cyclase activity over the course of the assay. Purified protein kinase C can reconstitute calcium- and phorbol ester-dependent adenylate cyclase. Phorbol ester-activated protein kinase C increases both the initial rate of cAMP synthesis and reduces the time-dependent decay of adenylate cyclase activity in membrane preparations. The rate of cAMP production is fit to an equation derived from a model which assumes that adenylate cyclase initially exists in a high activity state which decays exponentially into a low activity state. We suggest that protein kinase C can both prevent the decay of the high activity state and convert the low activity state into the high activity state.

Adenylyl Cyclases↗
PubMed1987

Differences between human and goose erythrocytes in response to phorbol esters and expression of phorbol ester receptors.

Phorbol esters inhibited the uptake of a fluorescent glucose analogue in goose but not in human erythrocytes. Specific phorbol-12,13-dibutyrate (PDB) binding sites were identified in both goose and human erythrocytes. In the absence of Ca2+ and phospholipid, PDB binding in whole cell lysates was similar to that in intact cells, but addition of Ca2+ (0.5 mM) and phosphatidyl serine (96 micrograms/ml) caused a 4-fold increase in the binding detected in lysates. Nonlinear least-squares analysis of the PDB binding isotherm revealed that the data for lysates from both goose and human cells were best fit by a two-site model, with goose erythrocytes having approximately 3 times as many sites per class of receptors. Subcellular fractionation of human lysates indicated that the high (Kd = 3.6 +/- 2.2 nM) and low (Kd = 20 +/- 5 nM) affinity sites could be accounted for by the contributions from cytosol and crude membrane, respectively. Separation of the high and low affinity sites was not achieved in goose lysates. PDB binding to intact goose erythrocytes exhibited the lower affinity (Kd approximately 30 nM) and was enhanced approximately 2-fold by incubation at 37 degrees C relative to incubation at 4 degrees C. This was due to an increased Bmax, with no change in Kd of the whole cell binding. Human erythrocytes did not demonstrate this temperature-enhanced binding of PDB to intact cells. These data are consistent with a temperature-induced translocation of PDB receptors from cytosol to membrane in goose erythrocytes. The failure of human erythrocytes to respond to PDB is not due to an absence of PDB receptors but may be related to the diminished number of receptors or to the lack of a temperature-induced increase in whole cell receptor number.

4-Chloro-7-nitrobenzofurazan↗
PubMed1987

Absence of protein kinase C in nuclei of EL4 mouse thymoma cells.

Since evidence indicates that phorbol ester-induced production of interleukin 2 requires transcription, we investigated the possibility that the phorbol ester receptor acts directly in the nuclei of EL4 thymoma cells. Using a procedure that minimized plasma membrane contamination (as measured by 5'-nucleotidase activity) and maintained the integrity of the double nuclear membrane, we were unable to detect specific binding of [3H]phorbol 12,13-dibutyrate in nuclei of unstimulated cells. Treatment of cells with phorbol 12,13-dibutyrate (100 nM, 37 degrees C) for up to 6 h did not cause appearance of phorbol ester binding capacity in nuclei (4 +/- 8% of homogenate value; 5'-nucleotidase activity = 10 +/- 3%) despite translocation of 40% of the cytosolic binding capacity to the plasma membrane fraction. The failure to detect nuclear binding capacity in treated cells was not due to occupation of nuclear sites with unlabeled ligand; effective exchange binding was demonstrated by recovery of total homogenate binding capacity in treated cells of 82 +/- 13% of that in untreated cells. Treatment of isolated nuclei with DNase to liberate DNA binding proteins also failed to reveal any nuclear phorbol ester binding capacity. Assay of nuclei for protein kinase C enzymatic activity gave similar negative results. These data argue strongly against a direct action of the intact phorbol ester receptor (or the phorbol ester binding fragment) in the transcriptional activation of interleukin 2 in EL4 cells but cannot rule out the possibility of a role for the catalytic fragment.

5'-Nucleotidase↗
PubMed1987

Phorbol esters induce interleukin 2 mRNA in sensitive but not in resistant EL4 cells.

Phorbol ester sensitive EL4 cells become growth-inhibited and produce interleukin 2 when treated with phorbol-12, 13-dibutyrate. Resistant cells lack both responses. To determine whether the defect in phorbol ester-resistant EL4 cells occurs pre- or post-transcriptionally, a hybridization assay for interleukin 2 mRNA was developed using two synthetic oligonucleotides complementary to mouse interleukin 2 mRNA as probes. Both probes hybridized to a 1-kilobase band in RNA from phorbol ester-treated sensitive cells. This RNA was detectable within 3 h of phorbol ester administration, and accumulation peaked by 12 h. The 1-kilobase band was induced in a concentration-dependent manner by 4-beta-phorbol-12, 13-dibutyrate but not by the inactive analog, 4-alpha-phorbol-12, 13-dibutyrate. No bands hybridizing with the interleukin 2 probe were detected in RNA isolated from unstimulated cells or from phorbol ester-resistant EL4 cells at any time up to 24 h following phorbol ester stimulation. The accumulation of the RNA in sensitive cells was blocked when the protein synthesis inhibitors, cycloheximide (75 microM) or puromycin (90 microM) were added within 1 h of the addition of phorbol ester. If cycloheximide was added 2 or more h after phorbol ester treatment, superinduction of the 1-kilobase band was observed. These results indicate that the failure of phorbol ester-resistant EL4 cells to produce interleukin 2 is due to a defect proximal to interleukin 2 transcription and that the accumulation of interleukin 2 mRNA in phorbol ester-sensitive EL4 cells requires protein synthesis.

Animals↗
PubMed1987

Inhibition of hemopoietic growth factor-induced proliferation by adenosine diphosphate-ribosylation inhibitors.

The effects of adenosine diphosphate (ADP) ribosylation inhibitors on hematopoietic growth factor-induced proliferation were examined. Significant inhibition of interleukin-3 (IL-3), colony-stimulating factor 1, and lung conditioned media-induced clonal agar growth of normal murine hematopoietic cells by 10 mmol/L nicotinamide (NAM), 10 mmol/L 3-aminobenzamide (3AB), and 5 mmol/L N1-methylnicotinamide (1MN) was noted. Nicotinic acid, a related compound that does not inhibit ADP ribosylation, failed to inhibit the growth factor-mediated proliferation. NAM (10 mmol/L), 3AB (10 mmol/L), and 1MN (5 mmol/L) also prevented IL-3 and phorbol ester-stimulated 3H-thymidine incorporation into the IL-3-responsive FDC-P1 cell line. Exposure of FDC-P1 cells to 10 mmol/L NAM led to a significant decrease in nuclear poly-(ADP-ribose) levels. Exposure of FDC-P1 cells to 5 mmol/L 1MN did not affect the interaction of the phorbol ester receptor, protein kinase-C (PK-C), with the cell membrane as determined by assay of phorbol ester binding in cytosol and membrane preparations. Nor did it affect the catalytic activity of PK-C as determined by assaying the in vitro phosphorylation of histone H1 by cytosolic kinase preparations from FDC-P1 as well as EL4 thymoma cells. 1MN markedly enhanced the inhibitory effects of phorbol esters on DNA synthesis of EL4 cells even at concentrations (1.25 mmol/L) that had no effects on DNA synthesis in the absence of phorbol esters. Our findings demonstrate that (a) active ADP ribosylation inhibitors interfere with growth factor-induced proliferation of murine hematopoietic cells and (b) the inhibition occurs at a step that follows the activation and translocation of PK-C and is more closely linked to DNA synthesis.

Adenosine Diphosphate↗
PubMed1986

Lack of direct effect of 2,3,7,8-tetrachlorodibenzo-P-dioxin (TCDD) on protein kinase C activity in EL4 cells.

In vivo administration of TCDD produces an increase in the level of Protein Kinase C in the hepatic plasma membrane. We have studied the direct effects of TCDD on cultured EL4 thymoma cells, which contain a large amount of Protein Kinase C and respond to phorbol esters with rapid translocation of the kinase to the membrane, followed by growth inhibition, adherence to substrate and production of interleukin 2. TCDD (10-1000 nM) did not compete with 3H-phorbol dibutyrate for binding to cytosolic Protein Kinase C, and had no effect on Protein Kinase C activity in vitro. TCDD did not stimulate translocation of Protein Kinase C to the membrane, and did not affect phorbol ester-stimulated translocation. TCDD did not inhibit EL4 cell growth or affect phorbol ester induced growth inhibition, and failed to stimulate production of interleukin 2. Thus, TCDD does not appear to activate Protein Kinase C in EL4 cells.

Cell Line↗
PubMed1986

Inhibition of phorbol ester stimulated interleukin 2 production by copper(II) complexes.

Superoxide dismutase mimetic copper(II) complexes, such as copper(II)(3,5-diisopropylsalicylate)2 (CuDIPS), inhibit phorbol ester stimulated tumor promotion in mouse skin. Therefore, CuDIPS was tested as a potential inhibitor of another effect of phorbol esters, induction of interleukin 2 (IL2) synthesis, in the mouse thymoma cell line EL4. CuDIPS inhibited phorbol ester induced IL2 production in a concentration dependent manner with a 50% inhibitory concentration of about 10 microM. However, the ligand 3,5-diisopropylsalicylic acid also inhibited the induction of IL2 by phorbol esters (50% inhibitory concentration, 15 microM). Since the superoxide dismutase mimetic activity of CuDIPS is not stable in the presence of ethylenediaminetetraacetic acid, the effects of CuDIPS could be due to the free ligand and not to the intact metallocomplex. Consequently, a series of extremely stable copper(II) macrocyclic compounds was synthesized, and the reduction potential, superoxide dismutase mimetic activity, and ability to inhibit phorbol ester induced IL2 production were determined for each. Of the copper(II) macrocyclic complexes studied, only the most potent superoxide dismutase mimetic compound was found to inhibit phorbol ester induced IL2 production. Copper(II) complexes had to be added no later than 4 following phorbol ester administration to be effective inhibitors of the IL response, suggesting that these compounds act subsequent to the binding of phorbol esters but prior to the transcription of IL2 messenger RNA. Adherence of EL4 cells to substrate in response to phorbol esters was unaffected by copper(II) compounds. In summary, copper(II) compounds with appropriate reduction potentials can act within a defined time period to inhibit some, but not all, of the effects of phorbol esters on EL4 cells.

Animals↗
PubMed1986

Substrates for protein kinase C in cytosol of EL4 mouse thymoma cells.

Phorbol esters trigger production of interleukin 2 by EL4 thymoma cells via an interaction with specific receptors, now considered to be identical with protein kinase C. Several in vitro substrates for protein kinase C were characterized by incubating cytosol from phorbol ester-responsive and -nonresponsive cells with [32P]adenosine triphosphate and CaCl2 with or without phosphatidylserine and diolein and separating proteins by gel electrophoresis. Phosphorylation of these proteins was calcium dependent in the range of 1-100 microM and stimulated by 10-150 micrograms of phosphatidylserine per ml. Calcium concentrations above 500 microM inhibited 32P incorporation and decreased phospholipid stimulation. Phorbol-12-myristate-13-acetate stimulated phosphorylation of these proteins, with a maximal concentration of 10 nM, providing strong evidence that these are protein kinase C substrates. The substrates for protein kinase C coeluted with the enzyme after binding to a phosphatidylserine affinity column in a calcium-dependent manner. Molecular weights of the protein kinase C substrates in sensitive cell cytosol were approximately 92,000, 84,000, 70,000, 67,000, 53,000, 45,000, 40,000, 36,000, and 20,000. A similar EL4 line which has phorbol ester receptors and protein kinase C, but does not produce interleukin 2 in response to phorbol esters, lacked the Mr 45,000 substrate and often also lacked the Mr 40,000 and 36,000 substrates. These proteins were also analyzed by two-dimensional electrophoresis. These results provide evidence of differences in the two cell lines in the ability of some proteins to serve as substrates for protein kinase C. Four proteins in a highly purified preparation of protein kinase C, at molecular weights of 66,000, 74,000, and 78,000 (all with pI 6.5-7.1) and of 62,000 (pI 6.2-6.4), were protein kinase C substrates, one of which is probably protein kinase C.

Animals↗